In conclusion, the results of the present study allow generation of the hypothesis that serum BChE is a possible novel, independent biomarker predicting PFS, CSS, and OS in patients with LACC and early stage cervical cancer with lymph node metastases treated with primary (chemo-)radiation therapy. The gene discussed is BCHE; the disease is cervical cancer.